Literature DB >> 36040475

Low muscle mass and high visceral fat mass predict mortality in patients hospitalized with moderate-to-severe COVID-19: a prospective study.

Fabyan Esberard de Lima Beltrão1,2,3, Daniele Carvalhal de Almeida Beltrão3,4, Giulia Carvalhal5, Fabyo Napoleão de Lima Beltrão6, Igor Motta de Aquino7, Thaíse da Silva Brito8, Barbara Costa Paulino2, Elisa Aires9, Diana Viegas10, Fabio Hecht11, Bruno Halpern12, Liana Clebia De Morais Pordeus4, Maria da Conceição Rodrigues Gonçalves2, Helton Estrela Ramos9,13,14.   

Abstract

Introduction: The severity of coronavirus disease 2019 (COVID-19) has been positively correlated with several comorbidities. The primary outcome of the study was to assess the relationship between the mortality and severity of COVID-19 and obesity classes according to BMI, visceral adipose tissue (VAT) area, s.c. adipose tissue area, muscle area (MA), and leptin levels.
Methods: In this prospective cohort study, 200 patients hospitalized with moderate-to-severe COVID-19 underwent an unenhanced CT of the thorax and laboratory tests, and leptin levels between June and August 2020 were obtained.
Results: Our study included 200 patients (male 52%; mean age: 62 (49-74) years; obesity (BMI > 30): 51.5%)). Fifty-eight patients (23.5%) were admitted to the intensive care unit and 29 (14.5%) died. In multivariate logistic regression (corrected for leptin, sex, age, and serum biomarkers) and receiver operating characteristic curve analyses, high VAT > 150 cm2 (odds ratio (OR): 6.15; P < 0.002), MA < 92 cm2 (OR: 7.94; P < 0.005), and VAT/MA ratio > 2 (OR: 13.9; P < 0.0001) were independent risk factors for mortality. Indeed, the Kaplan-Meier curves showed that patients with MA < 92 cm2 and without obesity (BMI < 30) had a lower survival rate (hazard ratio between 3.89 and 9.66; P < 0.0006) than the other groups. Leptin levels were not related to mortality and severity.
Conclusion: This prospective study reports data on the largest number of hospitalized severe COVID-19 patients and pinpoints VAT area and MA calculated by CT as predictors of COVID-19 mortality.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; obesity; visceral adipose tissue

Year:  2022        PMID: 36040475      PMCID: PMC9578108          DOI: 10.1530/EC-22-0290

Source DB:  PubMed          Journal:  Endocr Connect        ISSN: 2049-3614            Impact factor:   3.221


  37 in total

1.  Crystal structure of the obese protein leptin-E100.

Authors:  F Zhang; M B Basinski; J M Beals; S L Briggs; L M Churgay; D K Clawson; R D DiMarchi; T C Furman; J E Hale; H M Hsiung; B E Schoner; D P Smith; X Y Zhang; J P Wery; R W Schevitz
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

2.  Leptin stimulates bone formation in ob/ob mice at doses having minimal impact on energy metabolism.

Authors:  Kenneth A Philbrick; Carmen P Wong; Adam J Branscum; Russell T Turner; Urszula T Iwaniec
Journal:  J Endocrinol       Date:  2017-01-05       Impact factor: 4.286

Review 3.  Obesity, Fat Mass and Immune System: Role for Leptin.

Authors:  Vera Francisco; Jesús Pino; Victor Campos-Cabaleiro; Clara Ruiz-Fernández; Antonio Mera; Miguel A Gonzalez-Gay; Rodolfo Gómez; Oreste Gualillo
Journal:  Front Physiol       Date:  2018-06-01       Impact factor: 4.566

4.  Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19.

Authors:  Mikiko Watanabe; Damiano Caruso; Dario Tuccinardi; Renata Risi; Marta Zerunian; Michela Polici; Francesco Pucciarelli; Mariarita Tarallo; Lidia Strigari; Silvia Manfrini; Stefania Mariani; Sabrina Basciani; Carla Lubrano; Andrea Laghi; Lucio Gnessi
Journal:  Metabolism       Date:  2020-07-23       Impact factor: 8.694

Review 5.  Obesity and impaired metabolic health in patients with COVID-19.

Authors:  Norbert Stefan; Andreas L Birkenfeld; Matthias B Schulze; David S Ludwig
Journal:  Nat Rev Endocrinol       Date:  2020-07       Impact factor: 43.330

6.  The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany.

Authors:  Antonia Petersen; Keno Bressem; Jakob Albrecht; Hans-Martin Thieß; Janis Vahldiek; Bernd Hamm; Marcus R Makowski; Alexandra Niehues; Stefan M Niehues; Lisa C Adams
Journal:  Metabolism       Date:  2020-07-14       Impact factor: 8.694

7.  Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue.

Authors:  Peter H J van der Voort; Jill Moser; Durk F Zandstra; Anneke C Muller Kobold; Marjolein Knoester; Cornelis F Calkhoven; Inge Hamming; Matijs van Meurs
Journal:  Heliyon       Date:  2020-08-20

Review 8.  Obesity and COVID-19 in Latin America: A tragedy of two pandemics-Official document of the Latin American Federation of Obesity Societies.

Authors:  Bruno Halpern; Maria Laura da Costa Louzada; Pablo Aschner; Fernando Gerchman; Imperia Brajkovich; José Rocha Faria-Neto; Felix Escaño Polanco; Julio Montero; Silvia María Marín Juliá; Paulo Andrade Lotufo; Oscar H Franco
Journal:  Obes Rev       Date:  2020-11-23       Impact factor: 10.867

Review 9.  Epidemiological analysis of COVID-19 and practical experience from China.

Authors:  Qing Ye; Bili Wang; Jianhua Mao; Junfen Fu; Shiqiang Shang; Qiang Shu; Ting Zhang
Journal:  J Med Virol       Date:  2020-04-10       Impact factor: 20.693

10.  Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19.

Authors:  Luigi Di Filippo; Rebecca De Lorenzo; Clara Sciorati; Annalisa Capobianco; Nicola I Lorè; Andrea Giustina; Angelo A Manfredi; Patrizia Rovere-Querini; Caterina Conte
Journal:  Diabetes Metab       Date:  2021-07-29       Impact factor: 6.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.